B D Kan, D A Katz. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Anticoagulants/economicsAnticoagulants/therapeutic useAspirin/economicsAspirin/therapeutic useAtrial Fibrillation/drug therapyAtrial Fibrillation/physiopathologyCerebrovascular Disorders/etiologyCerebrovascular Disorders/prevention & controlCost-Benefit AnalysisHumansPlatelet Aggregation Inhibitors/economicsPlatelet Aggregation Inhibitors/therapeutic useWarfarin/economicsWarfarin/therapeutic use
Substances： See more » AnticoagulantsPlatelet Aggregation InhibitorsWarfarinAspirin
Year: 1996 PMID： 8598612 DOI： 10.1001/jama.275.12.909
Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272